Letter to the National Government Services Medical Policy Unit Regarding the Proposed Local Coverage Determination — Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms
On behalf of the Coalition for 21st Century Medicine (C21), we appreciate the opportunity to submit comments regarding the above-captioned proposed Local Coverage Determination (LCD).
…C21 member companies currently offer and/or are actively developing next generation sequencing (NGS)-based comprehensive genomic profiles (CGPs) for patients with advanced cancer. Given C21’s mission to facilitate the development and commercialization of innovative diagnostics, C21 has a keen interest in National Government Services’ consideration of the above-captioned proposed LCD.
C21 strongly supports the proposed LCD insofar as it would expand coverage for NGS-based CGPs offered as laboratory-developed tests (LDTs), as permitted under National Coverage Determination (NCD) 90.2.